Archives
Syringin Targets EGFR/PI3K/Akt in RCC
2026-09-08
A 2024 Journal of Functional Foods study identifies Syringin as a candidate natural product for renal cell carcinoma (RCC), linking its effects to EGFR/PI3K/Akt signaling and increased sunitinib sensitivity. Its combination of network pharmacology, molecular docking, bioinformatics, and cell-based validation provides a mechanistic framework for studying targeted-therapy resistance, while remaining preliminary because in vivo and clinical evidence is not established.
Cy5-UTP: An Assay-Design Guide for RNA Delivery
2026-09-07
Cy5-UTP enables direct fluorescent RNA tracking from in vitro transcription RNA labeling to delivery-assay development. This guide explains how Cyanine 5-uridine triphosphate can support FISH, RNA probe synthesis, and mechanistically informed mRNA delivery studies without confusing tracer behavior with therapeutic function.
Adamtsl3–MMP9 Control of Cortical Plasticity
2026-09-07
The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons and links its loss to excessive MMP9 activity, oxidative stress, and renewed adult cortical plasticity. Its genetic, imaging, biochemical, and behavioral framework provides a useful basis for studying extracellular-matrix remodeling in schizophrenia-relevant circuit dysfunction and for evaluating carefully controlled gelatinase-inhibition experiments.
NSC23766: Rac GTPase Inhibitor Workflows
2026-09-05
NSC23766 enables controlled interrogation of Rac-dependent cytoskeletal behavior, from macrophage phagocytosis to endothelial barrier disruption and breast cancer phenotypes. This guide pairs mechanism-focused assay design with dosing, controls, and troubleshooting strategies that help distinguish Rac biology from nonspecific toxicity.
GSK J4 HCl: JMJD3 Inhibition in Cell Models
2026-09-05
GSK J4 HCl provides a practical way to perturb H3K27 demethylation in macrophage inflammation, chromatin, and cancer workflows. This guide translates a decidual histone-methylation study into assay-ready designs while emphasizing controls, solvent handling, and interpretation limits.
EZ Cap™ Firefly Luciferase mRNA as an LNP Calibrator
2026-09-04
EZ Cap™ Firefly Luciferase mRNA can function as more than a reporter: it can help separate delivery, translation, and assay effects in RNA experiments. This article connects Cap1 mRNA design with lipid nanoparticle size, experimental controls, and in vivo bioluminescence imaging decisions.
Cl-Amidine for PAD4 and AML Research
2026-09-04
Cl-Amidine (trifluoroacetate salt) gives researchers a controlled way to test how PAD4-dependent histone citrullination and inflammatory signaling intersect with AML biology. This guide combines biochemical validation, cell-based perturbation, chromatin readouts, and septic shock model considerations with practical handling and troubleshooting advice.
BMS-345541: From IKK Blockade to Assay Logic
2026-09-03
BMS-345541 is an IKK-1/IKK-2 inhibitor for dissecting NF-κB-dependent inflammation, angiogenesis, and cancer phenotypes. This article translates mechanistic evidence into assay-design decisions, emphasizing how to distinguish pathway inhibition from downstream biological effects.
RHEB Neddylation Activates mTORC1 in Liver Cancer
2026-09-02
The reference study identifies RHEB as a non-cullin substrate of the UBE2F-SAG neddylation axis and maps the functionally important modification to lysine 169. By connecting this modification to lysosome localization, GTP binding, mTORC1 signaling, and liver tumorigenesis, the work provides a mechanistic framework for studying neddylation in liver disease.
Erastin Workflow for Ferroptosis Research
2026-09-02
Build a controlled Erastin workflow to connect RAS/BRAF genotype, cystine–glutathione stress, and ferroptotic cell death. The guide combines practical dosing, orthogonal oxidative stress readouts, pancreatic cancer applications, and troubleshooting for reproducible cancer biology research.
Carbapenemase Gene Spread in CREC Hospitals
2026-09-01
Chen and colleagues combined gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element analysis, and ERIC-PCR typing to examine carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. The findings emphasize plasmid-associated blaNDM-1, efficient laboratory transfer of carbapenemase-encoding genes, and genetically related isolates distributed across departments and hospitals.
ZK53 Activates ClpP in Lung Squamous Cancer
2026-09-01
The reference study identifies ZK53 as a selective activator of human mitochondrial ClpP and shows that excessive ClpP activity disrupts respiratory-chain proteostasis in lung squamous cell carcinoma. By connecting mitochondrial ATP loss with E2F-target suppression, ATM-mediated DNA damage response signaling, and cell-cycle arrest, the work establishes a mechanistic framework for targeting mitochondrial quality control in LUSC.
Gut Microbial H2S Suppresses GLP-1 in Male Mice
2026-08-31
The reference study identifies Desulfovibrio-derived hydrogen sulfide as a gut-to-host metabolic signal that suppresses GLP-1 production in male mice. By linking microbial H2S to impaired mitochondrial respiration and the unfolded protein response in intestinal L cells, the work provides a mechanistic framework for how dysbiosis may contribute to metabolic syndrome and shows that bismuth subsalicylate can improve metabolic outcomes in the tested models.
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-31
Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and converted into epithelial monolayers containing enterocytes with cytochrome P450 and transporter activities, creating a more human-relevant platform for pharmacokinetic studies.
Lipo3K Transfection Reagent for PTX-Resistance Studies
2026-08-30
Use Lipo3K Transfection Reagent to build reproducible DNA, siRNA, mRNA, and co-transfection workflows in resistant breast cancer models. Its low-toxicity cationic lipid chemistry is particularly useful when transporter perturbation, drug accumulation, and cell viability must be measured in the same experiment.
3584 records 9/239 page Previous Next First page 上5页 678910 下5页 Last page